Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
3.38M
-
Shares change
-
-2.09M
-
Total reported value, excl. options
-
$3.45M
-
Value change
-
-$2.25M
-
Put/Call ratio
-
0.59
-
Number of buys
-
10
-
Number of sells
-
-45
-
Price
-
$1.02
Significant Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q3 2024
74 filings reported holding PLX - Protalix BioTherapeutics, Inc. - COM as of Q3 2024.
Protalix BioTherapeutics, Inc. - COM (PLX) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.38M shares
.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (956K shares), GSA CAPITAL PARTNERS LLP (435K shares), MILLENNIUM MANAGEMENT LLC (374K shares), Stratos Wealth Partners, LTD. (270K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (184K shares), BlackRock, Inc. (179K shares), CITADEL ADVISORS LLC (91.7K shares), Orin Green Financial, LLC (72K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (70.8K shares), and Squarepoint Ops LLC (55.4K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.